Literature DB >> 6597126

Natural cytotoxicity of human blood monocytes: production of monocyte cytotoxic factors (MCF) during interaction with tumor cells.

A Uchida, E Yanagawa.   

Abstract

Human blood monocytes obtained by EDTA-reversible adherence to autologous serum-coated plastic dishes expressed natural cytotoxicity against NK-sensitive K562 cells in a 4-h 51Cr release assay. These monocytes released soluble cytotoxic factors, termed monocyte cytotoxic factors (MCF), when cultured with target cells. In contrast, blood monocytes obtained by adherence to fetal calf serum-coated plastic surfaces failed to kill K562 cells and to produce MCF. Although some lysis could be detected at 18 h, optimal lysis of K562 cells by MCF was observed after 48 h incubation in a microcytotoxicity assay using trypan blue dye exclusion. The addition of actinomycin D to the cytotoxicity assay enhanced the sensitivity and then NCF activity was detectable in a 18-h Cr release assay. Neither supernatants produced by culture of monocytes alone nor lysates of monocytes were cytotoxic. In addition, cytochalasin A inhibited both direct cell-mediated lysis and generation of MCF. Optimal production of MCF occurred after 6-24 h of interaction with K562 cells, although significant activity was already present by 3 h. Treatment of monocytes with OKM1 monoclonal antibody plus complement abrogated both cell-mediated lysis and MCF generation, whereas Leu-11b plus complement were ineffective. These results indicate that human blood monocytes can release MCF during interaction with tumor cells and that this may be involved in the lytic mechanism of monocyte-mediated natural cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6597126     DOI: 10.1016/0165-2478(84)90016-6

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

1.  Lysing of fresh human tumor by a cytotoxic factor derived from autologous large granular lymphocytes independently of other known cytokines.

Authors:  A Uchida; T Fujimoto; Y Mizutani
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  WEHI 164 sarcoma cells rendered resistant to monocyte-released cytotoxin are also resistant to monocyte-induced cytolysis.

Authors:  O Kildahl-Andersen; R Austgulen; J Nissen-Meyer
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  In vitro modulation of natural killer cell activity in non-Hodgkin's lymphoma patients after therapy.

Authors:  B A Mehta; M N Satam; S H Advani; J J Nadkarni
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patients.

Authors:  E Yanagawa; A Uchida; M Moore; M Micksche
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells.

Authors:  Clotilde Hoyos; Alexis Fontaine; Jean-Rock Jacques; Vincent Heinen; Renaud Louis; Bernard Duysinx; Arnaud Scherpereel; Eric Wasielewski; Majeed Jamakhani; Malik Hamaidia; Luc Willems
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

6.  Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.

Authors:  H Yamaue; H Tanimura; M Iwahashi; M Tani; T Tsunoda; K Tabuse; K Kuribayashi; K Saito
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.